Printer Friendly

Paradigm obtains United States patent.

Paradigm Genetics, Inc. (Research Triangle Park, NC) has patented a method of visually identifying plants transformed with a nucleotide sequence (e.g., a heterologous gene) using morphological markers. The nucleotide sequence is transformed into a plant that exhibits an abnormal phenotype for a morphological marker. If the transformation of the plant is successful, the progeny of the transformed plant will exhibit a normal phenotype. In a preferred embodiment, the plant is Arabidopsis and the morphological marker is Gl1, which is associated with trichome production on plant leaves. The method is also useful for identifying plants that are homozygous for the transformed gene, and for identifying transformants in the T2 generation that are true crosses, rather than self-crosses. (US 6,617,494)
COPYRIGHT 2003 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Paradigm Genetics Inc.
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 1, 2003
Previous Article:Sumitomo obtains United States patent.
Next Article:Meristem obtains United States patent.

Related Articles
Paradigm Genetics receives herbicide target patent.
Agilent enlists new life science partners. (Executive briefing: news, trends & market intelligence for instrument executives).
Paradigm Genetics enters biomarker research collaboration.
Paradigm Genetics announces new nutritional profiling method.
Paradigm Genetics receives patent for fungicide target.
Paradigm Genetics and Affymetrix sign microarray technology agreements.
Paradigm Genetics Inc.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters